These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28481738)

  • 1. Outcomes of Botulinum Toxin Type A for equinovarus deformity in patients with CVA: A case series.
    Karakkattil P; Trudelle-Jackson E; Brown HH; Hammontree P; Okolo M
    Physiother Theory Pract; 2017 May; 33(5):410-419. PubMed ID: 28481738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spasticity and Range of Motion Over Time in Stroke Patients Who Received Multiple-Dose Botulinum Toxin Therapy.
    Ro T; Ota T; Saito T; Oikawa O
    J Stroke Cerebrovasc Dis; 2020 Jan; 29(1):104481. PubMed ID: 31699575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of gait parameters to predict the effectiveness of botulinum toxin injection in the spastic rectus femoris muscle of stroke patients with stiff knee gait.
    Roche N; Boudarham J; Hardy A; Bonnyaud C; Bensmail B
    Eur J Phys Rehabil Med; 2015 Aug; 51(4):361-70. PubMed ID: 25213306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum Toxin Type A Treatment Combined with Intensive Rehabilitation for Gait Poststroke: A Preliminary Study.
    Uchiyama Y; Koyama T; Wada Y; Katsutani M; Kodama N; Domen K
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1975-1986. PubMed ID: 29610039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.
    Choi JY; Jung S; Rha DW; Park ES
    Yonsei Med J; 2016 Mar; 57(2):496-504. PubMed ID: 26847306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of botulinum toxin guided by electric stimulation on spasticity in ankle plantar flexor of children with cerebral palsy: a randomized trial].
    Xu KS; Yan TB; Mai JN
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):913-7. PubMed ID: 17254459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isokinetic assessment of the effects of botulinum toxin injection on spasticity and voluntary strength in patients with spastic hemiparesis.
    Hameau S; Bensmail D; Robertson J; Boudarham J; Roche N; Zory R
    Eur J Phys Rehabil Med; 2014 Oct; 50(5):515-23. PubMed ID: 24651151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of botulinum toxin injection on length and force of the rectus femoris and triceps surae muscles during locomotion in patients with chronic hemiparesis (FOLOTOX).
    Supiot A; Geiger M; Bensmail D; Aegerter P; Pradon D; Roche N
    BMC Neurol; 2018 Aug; 18(1):104. PubMed ID: 30068305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke.
    Reiter F; Danni M; Lagalla G; Ceravolo G; Provinciali L
    Arch Phys Med Rehabil; 1998 May; 79(5):532-5. PubMed ID: 9596394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of serial casting after botulinum toxin type A injection in improving equinovarus deformity in patients with chronic stroke.
    Yaşar E; Tok F; Safaz I; Balaban B; Yilmaz B; Alaca R
    Brain Inj; 2010; 24(5):736-9. PubMed ID: 20334469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ankle and Foot Spasticity Patterns in Chronic Stroke Survivors with Abnormal Gait.
    Li S
    Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33036356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Botulinum Toxin Type A a Valuable Adjunct During Femoral Lengthening? A Randomized Trial.
    Park H; Shin S; Shin HS; Kim HW; Kim DW; Lee DH
    Clin Orthop Relat Res; 2016 Dec; 474(12):2705-2711. PubMed ID: 27506971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course analysis of the effects of botulinum toxin type a on elbow spasticity based on biomechanic and electromyographic parameters.
    Lee HM; Chen JJ; Wu YN; Wang YL; Huang SC; Piotrkiewicz M
    Arch Phys Med Rehabil; 2008 Apr; 89(4):692-9. PubMed ID: 18374000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional outcomes following ultrasound-guided botulinum toxin type A injections to reduce spastic equinovarus in adult post-stroke patients.
    Aktürk S; Büyükavcı R; Ersoy Y
    Toxicon; 2018 May; 146():95-98. PubMed ID: 29530514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain and Muscles Properties Modifications After Botulinum Toxin Type A (BTX-A) and Radial Extracorporeal Shock Wave (rESWT) Combined Treatment.
    Megna M; Marvulli R; Farì G; Gallo G; Dicuonzo F; Fiore P; Ianieri G
    Endocr Metab Immune Disord Drug Targets; 2019; 19(8):1127-1133. PubMed ID: 30843498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of botulinum toxin-A on gait velocity, step length, and base of support of patients with dynamic equinovarus foot.
    Cioni M; Esquenazi A; Hirai B
    Am J Phys Med Rehabil; 2006 Jul; 85(7):600-6. PubMed ID: 16788391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment for flexed-elbow deformity during gait following botulinum toxin A treatment.
    Tanikawa H; Kagaya H; Inagaki K; Kotsuji Y; Suzuki K; Fujimura K; Mukaino M; Hirano S; Saitoh E; Kanada Y
    Gait Posture; 2018 May; 62():409-414. PubMed ID: 29649706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Faradic and Russian currents on plantar flexor muscle spasticity, ankle motor recovery, and functional gait in stroke patients.
    Ganesh GS; Kumari R; Pattnaik M; Mohanty P; Mishra C; Kaur P; Dakshinamoorthy A
    Physiother Res Int; 2018 Apr; 23(2):e1705. PubMed ID: 29417699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials.
    Jia S; Liu Y; Shen L; Liang X; Xu X; Wei Y
    J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104682. PubMed ID: 32305277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.